2024-01-25 08:59:14 ET
DENVER, Colo., Jan. 25, 2023 (www.247marketnews.com)- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) reported, this morning, the…
For further details see:
Processa Pharmaceuticals (NASDAQ: PCSA) Reports Successful Phase 1b Safety Evaluation Data
Disclaimer
This article is for the purposes of solicitation subscriptions for this website. This website expects to generate new advertisement revenue resulting from the distribution of this article. The amount of which is unknown at this time. This website or it’s authors do not own any shares of Processa Pharmaceuticals Inc. (PCSA) and does not buy, sell, or trade any shares of (PCSA). This article does not provide a professional analysis of a (PCSA) financial position. (PCSA) financial position and all other information regarding the featured Company should be verified directly with (PCSA). Please read our full disclaimer for more detailed information.
